Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysis ; volume:20 ; number:1 ; day:15 ; month:6 ; year:2020 ; pages:1-9 ; date:12.2020
BMC cancer ; 20, Heft 1 (15.6.2020), 1-9, 12.2020
- Creator
-
Vardarli, I.
Weidemann, F.
Aboukoura, M.
Herrmann, K.
Binse, I.
Görges, R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-020-07029-3
- URN
-
urn:nbn:de:101:1-2020081222302828383270
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
10.04.2025, 3:49 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vardarli, I.
- Weidemann, F.
- Aboukoura, M.
- Herrmann, K.
- Binse, I.
- Görges, R.
- SpringerLink (Online service)
Other Objects (12)
The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer
Comparison of radioiodine ablation rates between low versus high dose, and according to the surgeon's expertise in the low-risk group of differentiated thyroid cancer
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms
Global inflation: Low for long or higher for longer?
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
Management of low- and intermediate-risk prostate cancer
MRI for managing intermediate & low risk prostate cancer
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study
The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer
Comparison of radioiodine ablation rates between low versus high dose, and according to the surgeon's expertise in the low-risk group of differentiated thyroid cancer
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms
Global inflation: Low for long or higher for longer?
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
Management of low- and intermediate-risk prostate cancer
MRI for managing intermediate & low risk prostate cancer
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study
The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer
Comparison of radioiodine ablation rates between low versus high dose, and according to the surgeon's expertise in the low-risk group of differentiated thyroid cancer
Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms
Global inflation: Low for long or higher for longer?
Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma
Management of low- and intermediate-risk prostate cancer
MRI for managing intermediate & low risk prostate cancer